Design, Synthesis and Biological Activity of Novel Chalcone Derivatives as Anti-influenza Agents

A series of novel chalcone derivatives was designed and synthesized via a suitable synthetic strategy in good yields using commercially available 2-amino-4-nitrophenol as an initiator. The structures of the target compounds were confirmed by means of IH NMR, 13C NMR and high-resolution mass spectrom...

Full description

Saved in:
Bibliographic Details
Published in:Chemical research in Chinese universities Vol. 32; no. 1; pp. 28 - 34
Main Authors: Shi, Fangyuan, Fang, Hao, Xu, Wenfang
Format: Journal Article
Language:English
Published: Changchun Jilin University and The Editorial Department of Chemical Research in Chinese Universities 01-02-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of novel chalcone derivatives was designed and synthesized via a suitable synthetic strategy in good yields using commercially available 2-amino-4-nitrophenol as an initiator. The structures of the target compounds were confirmed by means of IH NMR, 13C NMR and high-resolution mass spectrometry(HRMS). And the ability of the target compounds to inhibit influenza viruses was evaluated. These compounds showed moderate inhi- bitory activity against influenza A(H9N2 and H5NI) viruses. Within this series, compounds S14 and S15 with good potency(IC50=40.3--51.5 μmol/L) could be used as lead compounds in the future.
Bibliography:22-1183/O6
Influenza virus; Inhibitor; Chalcone; Biological activity
A series of novel chalcone derivatives was designed and synthesized via a suitable synthetic strategy in good yields using commercially available 2-amino-4-nitrophenol as an initiator. The structures of the target compounds were confirmed by means of IH NMR, 13C NMR and high-resolution mass spectrometry(HRMS). And the ability of the target compounds to inhibit influenza viruses was evaluated. These compounds showed moderate inhi- bitory activity against influenza A(H9N2 and H5NI) viruses. Within this series, compounds S14 and S15 with good potency(IC50=40.3--51.5 μmol/L) could be used as lead compounds in the future.
ISSN:1005-9040
2210-3171
DOI:10.1007/s40242-015-5356-z